<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2618">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04316884</url>
  </required_header>
  <id_info>
    <org_study_id>EPN 2017/043 Covid19</org_study_id>
    <nct_id>NCT04316884</nct_id>
  </id_info>
  <brief_title>Mechanisms for Organ Dysfunction in Covid-19</brief_title>
  <acronym>UMODCOVID19</acronym>
  <official_title>Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate organ dysfunction and biomarkers in patients with suspected or
      verified COVID-19 during intensive care at Uppsala University Hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo
      daily blood, urine and sputum sampling during their stay in intensive care. Data on organ
      dysfunction will be collected through the electronic patient journal and electronic patient
      data management system. The collected samples will be analysed for a panel of potential
      biomarkers that will be correlated to organ dysfunction and clinical outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>During Intensive Care, an estimated average of 10 days.</time_frame>
    <description>KDIGO AKI score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ARDS</measure>
    <time_frame>During intensive care, an estimated average of 10 days.</time_frame>
    <description>Acute Respiratory Distress Syndrome yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death within 30 days of ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Death within 1 year of ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Kidney Disease</measure>
    <time_frame>60 days and 1 year after ICU admission</time_frame>
    <description>Development of Chronic Kidney Disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA-score</measure>
    <time_frame>During Intensive Care, an estimated average of 10 days.</time_frame>
    <description>Sequential Organ Failure Score as a continuous variable</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19</condition>
  <condition>Organ Dysfunction Syndrome Sepsis</condition>
  <condition>Organ Dysfunction Syndrome, Multiple</condition>
  <condition>Septic Shock</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>COVID-19</arm_group_label>
    <description>Patients with suspected or verified COVID-19 admitted to intensive care at Uppsala University Hospital</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, Urine and Sputum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients requiring intensive care with suspected or verified COVID19
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to intensive care

          -  suspected or verified COVID-19

        Exclusion Criteria:

          -  Pregnancy or breastfeeding

          -  Preexisting end-stage kidney failure or dialysis

          -  Under-age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Frithiof, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Frithiof, MD. PhD.</last_name>
    <phone>0736563473</phone>
    <email>robert.frithiof@surgsci.uu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Bülow Anderberg, MD.</last_name>
    <phone>0730247414</phone>
    <email>sarabulow@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Frithiof, MD. PhD.</last_name>
      <phone>073-6563473</phone>
      <email>robert.frithiof@surgsci.uu.se</email>
    </contact>
    <contact_backup>
      <last_name>Sara Bülow Anderberg, MD.</last_name>
      <phone>073-0247414</phone>
      <email>sarabulow@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Frithiof, MD. PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara Bülow Anderberg, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Hultström, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miklos Lipcsey, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 13, 2020</study_first_submitted>
  <study_first_submitted_qc>March 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2020</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
    <mesh_term>Multiple Organ Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD may be made available upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

